Compare $APRE vs $SNGX | Chartloom

Compare

$APRE vs $SNGX

Aprea Therapeutics Inc · Soligenix Inc

APRE

Aprea Therapeutics Inc

SNGX

Soligenix Inc

Compare $APRE vs $SNGX

Comparing Aprea Therapeutics Inc and Soligenix Inc

APREAprea Therapeutics Inc

SNGXSoligenix Inc

APREAprea Therapeutics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-99.4%

YTD performance

-29.1%

52W performance

-57.8%

FCF yield

-162.8%

SNGXSoligenix Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.4%

52W performance

-79.9%

FCF yield

-180.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APRE

SNGX

Detailed metrics comparison

APRE

Aprea Therapeutics Inc

SNGX

Soligenix Inc

Market Cap

APRE$7M

SNGX$5M

Enterprise Value

APRE$-34M

SNGX$-4M

Price

APRE$0.60

SNGX$0.36

P/E Ratio

APREN/A

SNGXN/A

P/S Ratio

APRE1,438.94x

SNGX16.09x

EV/Sales

APRE-6,490.56x

SNGX-3.76x

EV/EBITDA

APRE0.00x

SNGX-1.54x

P/B Ratio

APRE0.22x

SNGX1.20x

P/FCF Ratio

APREN/A

SNGXN/A

EV/FCF

APRE2.77x

SNGX0.45x

PEG Ratio

APREN/A

SNGXN/A

Forward P/E (NTM)

APREN/A

SNGXN/A

Forward P/S (NTM)

APREN/A

SNGXN/A

Revenue (TTM)

APRE$5K

SNGX$0

Revenue Growth (YoY)

APRE-99.4%

SNGXN/A

Forward Rev Growth

APRE445.8%

SNGX0.0%

Gross Margin (TTM)

APRE0.0%

SNGX8.8%

Operating Margin (TTM)

APRE0.0%

SNGX0.0%

EBITDA Margin (TTM)

APRE-253869.2%

SNGX0.0%

Net Margin (TTM)

APRE-236676.9%

SNGX0.0%

FCF Margin (TTM)

APRE-234296.2%

SNGXN/A

Net Income (TTM)

APRE$-12M

SNGX$-10M

FCF (TTM)

APRE$-12M

SNGX$-10M

EPS (TTM)

APRE-$0.23

SNGX-$0.64

ROE (TTM)

APRE-4630.0%

SNGX-18102.0%

ROA (TTM)

APRE-4097.0%

SNGX-10792.0%

ROIC (TTM)

APRE-4630.0%

SNGX-18102.0%

Cash

APRE$41M

SNGX$10M

Debt

APRE$0

SNGX$0

Net Cash/Debt

APRE$41M

SNGX$10M

Current Ratio (TTM)

APRE13.55x

SNGX2.77x

Quick Ratio (TTM)

APRE13.33x

SNGX2.67x

Debt/Equity (TTM)

APRE0.00x

SNGX0.00x

Debt/Assets (TTM)

APRE0.0%

SNGX0.0%

Interest Coverage (TTM)

APREN/A

SNGXN/A

Net Debt/EBITDA (TTM)

APRE0.00x

SNGX0.00x

Beta

APRE-1.23

SNGX2.15

52W Performance

APRE-57.8%

SNGX-79.9%

YTD Performance

APRE-29.1%

SNGX-74.4%

% from 52W High

APRE-64.2%

SNGX-81.5%

% from 52W Low

APRE10.3%

SNGX29.9%

Asset Turnover (TTM)

APRE0.02x

SNGX0.05x

FCF Yield (TTM)

APRE-162.8%

SNGX-180.8%

Earnings Yield (TTM)

APRE-164.5%

SNGX-190.0%

Dividend Yield (TTM)

APREN/A

SNGXN/A

Rule of 40

APRE-234,395.5

SNGX0.0

EV/GP/RG

APREN/A

SNGXN/A

Ticker research

View APRE research View SNGX research

Metric	APRE Aprea Therapeutics Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$7M	$5M
Enterprise Value	$-34M	$-4M
Price	$0.60	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	1,438.94x	16.09x
EV/Sales	-6,490.56x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	0.22x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	2.77x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5K	$0
Revenue Growth (YoY)	-99.4%	N/A
Forward Rev Growth	445.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-253869.2%	0.0%
Net Margin (TTM)	-236676.9%	0.0%
FCF Margin (TTM)	-234296.2%	N/A
Net Income (TTM)	$-12M	$-10M
FCF (TTM)	$-12M	$-10M
EPS (TTM)	-$0.23	-$0.64
ROE (TTM)	-4630.0%	-18102.0%
ROA (TTM)	-4097.0%	-10792.0%
ROIC (TTM)	-4630.0%	-18102.0%
Financial Health
Cash	$41M	$10M
Debt	$0	$0
Net Cash/Debt	$41M	$10M
Current Ratio (TTM)	13.55x	2.77x
Quick Ratio (TTM)	13.33x	2.67x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.23	2.15
52W Performance	-57.8%	-79.9%
YTD Performance	-29.1%	-74.4%
% from 52W High	-64.2%	-81.5%
% from 52W Low	10.3%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.05x
FCF Yield (TTM)	-162.8%	-180.8%
Earnings Yield (TTM)	-164.5%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-234,395.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APRE research	View SNGX research

Valuation

P/S Ratio

SNGX

16.09x

APRE

1,438.94x

EV/FCF

SNGX

0.45x

APRE

2.77x

Growth & revenue

Revenue Growth TTM

APRE

-99.4%

Forward Revenue Growth

APRE

445.8%

SNGX

0.0%

Profitability & performance

Gross Margin

SNGX

8.8%

APRE

0.0%

ROE

APRE

-4630.0%

SNGX

-18102.0%

FCF Yield %

APRE

-162.8%

SNGX

-180.8%

52-Week Performance

APRE

-57.8%

SNGX

-79.9%

Detailed metrics comparison

APRE

Aprea Therapeutics Inc

SNGX

Soligenix Inc

Market Cap

APRE$7M

SNGX$5M

Enterprise Value

APRE$-34M

SNGX$-4M

Price

APRE$0.60

SNGX$0.36

P/E Ratio

APREN/A

SNGXN/A

P/S Ratio

APRE1,438.94x

SNGX16.09x

EV/Sales

APRE-6,490.56x

SNGX-3.76x

EV/EBITDA

APRE0.00x

SNGX-1.54x

P/B Ratio

APRE0.22x

SNGX1.20x

P/FCF Ratio

APREN/A

SNGXN/A

EV/FCF

APRE2.77x

SNGX0.45x

PEG Ratio

APREN/A

SNGXN/A

Forward P/E (NTM)

APREN/A

SNGXN/A

Forward P/S (NTM)

APREN/A

SNGXN/A

Revenue (TTM)

APRE$5K

SNGX$0

Revenue Growth (YoY)

APRE-99.4%

SNGXN/A

Forward Rev Growth

APRE445.8%

SNGX0.0%

Gross Margin (TTM)

APRE0.0%

SNGX8.8%

Operating Margin (TTM)

APRE0.0%

SNGX0.0%

EBITDA Margin (TTM)

APRE-253869.2%

SNGX0.0%

Net Margin (TTM)

APRE-236676.9%

SNGX0.0%

FCF Margin (TTM)

APRE-234296.2%

SNGXN/A

Net Income (TTM)

APRE$-12M

SNGX$-10M

FCF (TTM)

APRE$-12M

SNGX$-10M

EPS (TTM)

APRE-$0.23

SNGX-$0.64

ROE (TTM)

APRE-4630.0%

SNGX-18102.0%

ROA (TTM)

APRE-4097.0%

SNGX-10792.0%

ROIC (TTM)

APRE-4630.0%

SNGX-18102.0%

Cash

APRE$41M

SNGX$10M

Debt

APRE$0

SNGX$0

Net Cash/Debt

APRE$41M

SNGX$10M

Current Ratio (TTM)

APRE13.55x

SNGX2.77x

Quick Ratio (TTM)

APRE13.33x

SNGX2.67x

Debt/Equity (TTM)

APRE0.00x

SNGX0.00x

Debt/Assets (TTM)

APRE0.0%

SNGX0.0%

Interest Coverage (TTM)

APREN/A

SNGXN/A

Net Debt/EBITDA (TTM)

APRE0.00x

SNGX0.00x

Beta

APRE-1.23

SNGX2.15

52W Performance

APRE-57.8%

SNGX-79.9%

YTD Performance

APRE-29.1%

SNGX-74.4%

% from 52W High

APRE-64.2%

SNGX-81.5%

% from 52W Low

APRE10.3%

SNGX29.9%

Asset Turnover (TTM)

APRE0.02x

SNGX0.05x

FCF Yield (TTM)

APRE-162.8%

SNGX-180.8%

Earnings Yield (TTM)

APRE-164.5%

SNGX-190.0%

Dividend Yield (TTM)

APREN/A

SNGXN/A

Rule of 40

APRE-234,395.5

SNGX0.0

EV/GP/RG

APREN/A

SNGXN/A

Ticker research

View APRE research View SNGX research

Metric	APRE Aprea Therapeutics Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$7M	$5M
Enterprise Value	$-34M	$-4M
Price	$0.60	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	1,438.94x	16.09x
EV/Sales	-6,490.56x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	0.22x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	2.77x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5K	$0
Revenue Growth (YoY)	-99.4%	N/A
Forward Rev Growth	445.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-253869.2%	0.0%
Net Margin (TTM)	-236676.9%	0.0%
FCF Margin (TTM)	-234296.2%	N/A
Net Income (TTM)	$-12M	$-10M
FCF (TTM)	$-12M	$-10M
EPS (TTM)	-$0.23	-$0.64
ROE (TTM)	-4630.0%	-18102.0%
ROA (TTM)	-4097.0%	-10792.0%
ROIC (TTM)	-4630.0%	-18102.0%
Financial Health
Cash	$41M	$10M
Debt	$0	$0
Net Cash/Debt	$41M	$10M
Current Ratio (TTM)	13.55x	2.77x
Quick Ratio (TTM)	13.33x	2.67x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.23	2.15
52W Performance	-57.8%	-79.9%
YTD Performance	-29.1%	-74.4%
% from 52W High	-64.2%	-81.5%
% from 52W Low	10.3%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.05x
FCF Yield (TTM)	-162.8%	-180.8%
Earnings Yield (TTM)	-164.5%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-234,395.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APRE research	View SNGX research